Bio-Techne Q4 Preview: NIH Funding Cut And Tariffs Impacts, Initiate At Sell

Bio-Techne Corporation (NASDAQ: TECH ) is the market leader in high-quality biological reagents used in the life science market, manufacturing high-quality proteins, antibodies and immunoassays. I think the company will benefit from the long-term growth in cellAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am ...